The presence of inducible cythochrome P450 types 1A1 and 1A2 in the BeWo cell line

Placenta

Volumn 24, Issue 1, 2003, Pages 45-52

  Avery, M L ^a   Meek, C E ^a   Audus, K L ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; ALPHA NAPHTHOFLAVONE; BENZ[A]ANTHRACENE; BETA NAPHTHOFLAVONE; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; ETHOXYRESORUFIN; FURAFYLLINE; ALPHA-NAPHTHOFLAVONE; BENZ[A]ANTHRACENE DERIVATIVE; BENZOFLAVONE DERIVATIVE; DRUG DERIVATIVE; ENZYME INHIBITOR; THEOPHYLLINE;

ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL CULTURE; CELL ISOLATION; CELLULAR DISTRIBUTION; CHORIOCARCINOMA; CIGARETTE SMOKING; CONTROLLED STUDY; CYTOTROPHOBLAST; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; LIVER MICROSOME; NONHUMAN; PLACENTA; PRIORITY JOURNAL; RAT; SENSITIVITY ANALYSIS; BIOSYNTHESIS; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME INDUCTION; ENZYMOLOGY; FEMALE; IC 50; SMOKING; TROPHOBLAST;

BENZ(A)ANTHRACENES; BENZOFLAVONES; BETA-NAPHTHOFLAVONE; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; ENZYME INHIBITORS; FEMALE; HUMANS; INHIBITORY CONCENTRATION 50; METHYLCHOLANTHRENE; MICROSOMES, LIVER; SMOKING; THEOPHYLLINE; TROPHOBLASTS; TUMOR CELLS, CULTURED;

EID: 0141615034     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.2002.0876     Document Type: Article

References (38)

1. Allen JR and Baarsotti DA (1976) The effects of transplacental and mammary movement of PCBs on infant rhesus monkeys. Toxicology, 6, 331-340.
2. Burke MD, Prough RA and Mayer RT (1978) Characteristics of a microsomal cytochrome P-448-mediated reaction ethoxyresorufin O-deethylation. Drug Metabolism and Disposition, 5, 1-8.
3. Burke MD, Thompson S, Elcombe CR, Halpert J, Haaparanta T and Mayer RT (1985) Ethoxy-, pentoxy-and benzylphenoxazones and homologues: a series substrates to distinguish between different induced cytochromes P-450. Biochemical Pharmacology, 34, 3337-3345.
4. Butler MA, Iwasaki M, Guengerich FP and Kadlubar FF (1989) Human cytochrome P-450pa (P-4501A2), the phenacetin O-deethylase, is primary responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proceedings of the National Academy of Science USA, 86, 7696-7700.
5. Dhawan A, Parmar D and Seth P (1999) Cytochrome P450 (P450) isoenzyme specific dealkylation of alkoxyresorufins in rat brain microsomes. Molecular and Cellular Biochemistry, 200, 169-176.
6. Dutton DR and Parkinson AR (1989) Reduction of 7-alkoxyresorufins by NADPH-cytochrome P450 reductase and its differential effects on their O-dealkylation by rat liver microsomal cytochrome P450. Archives of Biochemistry and Biophysics, 268, 617-629.
7. Eugster H-P, Probst M, Wurgler FE and Sengstang (1993) Caffeine, estradiol, and progesterone interact with human CYP1A1 and CYP1A2. Evidence from cDNA-directed expression in Saccharomyces cerevisiae. Drug Metabolism and Disposition, 21, 43-49.
8. Farin F and Omiecinski C (1993) Regiospecific expression of cytochrome P450s and microsomal epoxide hydroxylase in human brain tissue. Journal of Toxicology and Environmental Health, 40, 328-341.
9. Farin F, Pohlman T and Omiecinski C (1994) Expression of cytochrome P450s and microsomal epoxide hydrolase in primary cultures of human umbilical vein endothelial cells. Toxicology and Applied Pharmacology, 292, 1008-1014.
10. Hakkola J, Pasanen M and Raunio H (1996a) Expression of xenobiotic-metabolizing cytochrome P450 forms in human full-term placenta. Biochemical Pharmacology, 51, 403-411.
11. Hakkola J, Raunio H and Pasanen M (1996b) Detection of Cytochrome P450 gene expression in human placenta in first trimester of pregnancy. Biochemical Pharmacology, 52, 379-383.
12. Iba M, Fung J and Pak Y (1999) Dose-dependent up-regulation of rat pulmonary, renal, and hepatic cytochrome P-450 (CYP) 1A expression by nicotine feeding. Drug Metabolism and Disposition, 27, 977-982.
13. Kenagy J, Soares M and Audus K (1998) Gestational and smoking effects on peptidase activity in the placenta. Peptides, 19, 1659-1666.
14. Khera KS (1972) Pre-and postnatal studies on 2, 4, 5-trichlorophenoxyacetic acid, 2, 4-dichlorophenoxyacetic acid and their derivatives in rats. Toxicology and Applied Pharmacology, 22, 14-28.
15. Lee C and Riddick DS (2000) Transcriptional suppression of cytochrome P450 2C11 gene expression by 3-methylcholanthrene. Biochemical Pharmacology, 59, 1417-1423.
16. Liu F, Soares M and Audus K (1997) Permeability properties of monolayers of the human trophoblast cell line BeWo. American Journal of Physiology, 273, C1596-C1604.
17. Madan A, Dehaan R and Mudra D (1999) Effect of cryopreservation on cytochrome P-450 enzyme induction in cultured rat hepatocytes. Drug Metabolism and Disposition, 27, 327-335.
18. Mathis JM, Prough RA, Hines RN, Bresnick E and Simpson ER (1986) Regulation of cytochrome P-450c by glucocorticoids and polycyclic aromatic hydrocarbons in cultured fetal rat hepatocytes. Archives of Biochemistry and Biophysics, 246, 439-448.
19. McDonnell W, Scheiman J and Traber P (1992) Induction of cytochrome P4501A genes (CYP1A) by omperazole in the human alimentary tract. Gastroenterology, 103, 1509-1516.
20. Nakajima M, Ohyama K and Yokoi T (1999) Inhibitory effects of azelastine and its metabolites on drug oxidation catalyzed by human cytochrome P-450 enzymes. Drug Metabolism and Disposition, 27, 792-797.
21. Nemoto N and Sakurai J (1995) Glucocorticoid and sex hormones as activating or modulating factors for expression of Cyp2b-9 and Cyp2b-10 in the mouse liver and hepatocytes. Archives of Biochemistry and Biophysics, 319, 286-292.
22. Nerurkar PV, Park SS and Lubet RA (1993) Methoxyresorufin and benzyloxyresorufin: substrates preferentially metabolized by cytochromes P4501A2 and 2B, respectively, in the rat and mouse. Biochemical Pharmacology, 46, 933-943.
23. Pasanen M, Taskinen T, Sotaniemi EA, Kairaluoma M and Pelkonen O (1988) Inhibitor panel studies of human hepatic and placental cytochrome P-450 associated monooxygenase activities. Pharmacology and Toxicology, 62, 311-317.
24. Pasanen M and Pelkonen O (1990) Xenobiotic and steroid-metabolizing monooxygenases catalysed by cytochrome P450 and glutathione s-transferase conjugations in the human placenta and their relationships to maternal cigarette smoking. Placenta, 11, 75-82.
25. Pasanen M and Pelkonen O (1994) The expression and environmental regulation of P450 enzymes in Human Placenta. Critical Reviews in Toxicology, 24, 211-229.
26. Pasanen M, Haaparanta T and Sundin M (1990) Immunochemical and molecular biological studies on human placenta cigarette smoke-inducible cytochrome P450-dependent monooxygenase activities. Toxicology, 62, 175-187.
27. Pattillo RA and Gey GO (1968) The establishment of a cell line of human hormone-synthesizing trophoblastic cell in vitro. Cancer Research, 28, 1231-1236.
28. Pattillo RA, Hussa RO, Ruckert AC, Kurtz JW, Cade JM and Rinke ML (1979) Human chorionic gonadotropin in BeWo trophoblastic cells after 12 years in continuous culture: retention of intact human chorionic gonadotropin secretion in mechanically versus enzyme-dispersed cells. Endocrinology, 105, 967-974.
29. Pichard L, Fabre I and Fabre G (1990) Cyclosporin A drug interactions: Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes. Drug Metabolism and Disposition, 18, 595-606.
30. Prough RA, Linder MW, Pinaire JA, Xiao GH and Falkner KC (1996) Hormonal regulation of hepatic enzymes involved in foreign compound metabolism. FASEB, 10, 1369-1377.
31. Sakuma T, Ohtake M and Nemoto N (1999) Induction of CYP1A2 by phenobarbital in the livers of aryl hydrocarbon-responsive and -nonresponsive mice. Drug Metabolism and Disposition, 27, 379-384.
32. Sesardic AR, Boobis BP and Davies D (1990a) Furafylline is a potent and selective inhibitor of cytochrome P4501A2 in man. British Journal of Clinical Pharmacology, 29, 651-663.
33. Sesardic D, Pasanen M and Pelkonen O (1990b) Differential expresssion and regulation of the cytochrome P450IA gene subfamily in human tissues. Carcinogensis, 11, 1183-1188.
34. Shimada T, Gillam E and Sutter TR (1997) Oxidation of xenobiotics by recombinant human cytochrome P450 1B1. Drug Metabolism and Disposition, 29, 617-622.
35. Shum S, Jensen NM and Nebert DW (1979) The routine Ah locus: in utero toxicity and teratogenesis associated with genetic differences in benzo[a]pyrene metabolism. Teratology, 20, 365-376.
36. Sindhu R, Mitsuhashi M and Kikkawa Y (2000) Induction of cytochrome P-450 1A2 by tryptophan in Hepa IcIc7 cells. The Journal of Pharmacology and Experimental Therapeutics, 292, 1008-1014.
37. Vakharia D, Liu N and Kaminsky L (2001) Polycyclic aromatic hydrocarbon/metal mixtures: effect on PAH induction of CYP1A1 in human HEPG2 cells. Drug Metabolism and Disposition, 29, 999-1006.
38. Zevin S and Benowitz N (1999) Drug interactions with tobacco. An update. Clinical Pharmacokinetics, 36, 425-438.